查看完整行情页>>
|
货币单位:美元(USD)
阿尔尼拉姆制药公司
Alnylam Pharmaceuticals, Inc. (alny)
| 开盘价:-- |
最高价:-- |
最低价:-- |
52周最高价:-- |
52周最低价:-- |
| 成交量:-- |
平均成交量:-- |
市值:-- |
市盈率:-- |
预期市盈率:-- |
| 每股收益:-- |
贝塔系数:-- |
股息:-- |
收益率:-- |
总股本:-- |
| 机构持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| J.P. Morgan Investment Management, Inc. |
2667248 |
2.21% |
-943 |
-0.04% |
2022-05-31
|
| FMR Inc |
16045316 |
13.28% |
-1894704 |
-10.56% |
2022-03-31
|
| Vanguard Group Inc |
10829144 |
8.96% |
126373 |
1.18% |
2022-03-31
|
| Baillie Gifford & Co Limited. |
10139729 |
8.39% |
-477022 |
-4.49% |
2022-03-31
|
| Fidelity Management & Research Company LLC |
9007447 |
7.46% |
-489332 |
-5.15% |
2022-05-31
|
| BlackRock Inc |
7671402 |
6.35% |
-1249570 |
-14.01% |
2021-12-31
|
| Wellington Management Company LLP |
7034487 |
5.82% |
190057 |
2.78% |
2022-03-31
|
| T. Rowe Price Associates, Inc. |
6794166 |
5.62% |
258798 |
3.96% |
2022-03-31
|
| Capital World Investors |
5999674 |
4.97% |
5680728 |
1781.09% |
2022-03-31
|
| Capital Research and Management Company |
5862443 |
4.85% |
5543700 |
1739.24% |
2022-05-31
|
| Dodge & Cox |
5475668 |
4.53% |
44600 |
0.82% |
2022-03-31
|
| State Street Corporation |
2909490 |
2.41% |
59101 |
2.07% |
2022-03-31
|
| JPMorgan Chase & Co |
2919015 |
2.42% |
-53070 |
-1.79% |
2022-03-31
|
| Fidelity SelectCo, LLC |
3247981 |
2.69% |
-48535 |
-1.47% |
2022-05-31
|
| Fidelity Management Trust Company |
3467061 |
2.87% |
-322524 |
-8.51% |
2022-05-31
|
| Vanguard Investments Australia Ltd |
3548948 |
2.94% |
16110 |
0.46% |
2022-05-31
|
| BlackRock Fund Advisors |
4469237 |
3.70% |
23658 |
0.53% |
2022-05-31
|
| Capital Group |
4577261 |
3.79% |
4397705 |
2449.21% |
2022-05-31
|
| RTW INVESTMENTS, LLC |
1975879 |
1.64% |
292517 |
17.38% |
2021-12-31
|
| Manufacturers Life Insurance Co |
1702670 |
1.41% |
-28763 |
-1.66% |
2021-12-31
|
| FMR LLC |
16091945 |
13.33% |
16091945 |
-- |
2020-12-31
|
| Wellington Management Group, LLP |
10056940 |
8.33% |
10056940 |
-- |
2020-12-31
|
| Baillie Gifford & Co |
9132422 |
7.57% |
9132422 |
-- |
2020-12-31
|
| Morgan Stanley - Brokerage Accounts |
1880879 |
1.57% |
-1772 |
-0.09% |
2021-09-30
|
| Vanguard |
1924656 |
1.61% |
-28811 |
-1.47% |
2021-11-30
|
| Fidelity Management and Research Company |
17289312 |
14.55% |
1450275 |
9.16% |
2021-03-31
|
| Fidelity Management Trust Co |
4199679 |
3.57% |
10539 |
0.25% |
2021-04-30
|
| Wellington Investment Advisors Holdings LLP |
14286474 |
12.18% |
14286474 |
-- |
2019-12-31
|
| Massachusetts Financial Services Company |
1905390 |
1.64% |
842211 |
79.22% |
2020-09-30
|
| MFS Investment Management KK |
1905390 |
1.64% |
842211 |
79.22% |
2020-09-30
|
| Baillie Gifford Overseas Limited |
2030465 |
1.75% |
891482 |
78.27% |
2021-01-31
|
| JPMorgan Chase & Co |
2222887 |
1.91% |
1380042 |
163.74% |
2020-06-30
|
| Dodge & Cox |
4677613 |
4.03% |
-26058 |
-0.55% |
2020-09-30
|
| Baillie Gifford & Co Limited. |
8891488 |
7.65% |
242810 |
2.81% |
2020-09-30
|
| Fidelity Management & Research Company LLC |
9589623 |
8.25% |
-83236 |
-0.86% |
2020-11-30
|
| Bellevue Group AG |
1775264 |
1.53% |
-89519 |
-4.80% |
2020-03-31
|
| Bellevue Asset Management AG |
1653000 |
1.43% |
-81089 |
-4.68% |
2020-07-31
|
| Farallon Capital Management, L.L.C. |
1500000 |
1.29% |
50000 |
3.45% |
2020-03-31
|
| Fidelity Management & Research Company |
9995359 |
8.99% |
-532336 |
-5.06% |
2020-05-31
|
| Geode Capital Management, LLC |
1353928 |
1.22% |
-1125046 |
-45.38% |
2020-03-31
|
| Maverick Capital Ltd |
2260897 |
2.03% |
-961916 |
-29.85% |
2019-12-31
|
| Hartford Funds Management Company, LLC |
1813316 |
1.63% |
-426426 |
-19.04% |
2020-03-31
|
| RTW INNOVATION MASTER FUND LTD. |
1767628 |
1.59% |
-430466 |
-19.58% |
2019-09-30
|
| First Trust Advisors L.P. |
1192495 |
1.07% |
14439 |
1.23% |
2019-03-31
|
| UBS Asset Mgmt Americas Inc |
1417490 |
1.33% |
96532 |
7.31% |
2018-12-31
|
| Goldman Sachs Group Inc |
1119388 |
1.05% |
178810 |
19.01% |
2018-12-31
|
| Perceptive Advisors LLC |
1197994 |
1.13% |
-648917 |
-35.14% |
2018-09-30
|
| Orbimed Advisors, LLC |
1265966 |
1.25% |
-- |
-- |
2018-06-30
|
| BlackRock Institutional Trust Company NA |
2345836 |
2.32% |
-53856 |
-2.24% |
2018-06-30
|
| Point72 Asset Management, L.P. |
1356408 |
1.34% |
448362 |
49.38% |
2018-06-30
|
| Sanofi |
10554134 |
10.59% |
9268869 |
721.16% |
2017-12-31
|
| Morgan Stanley Investment Management Inc |
1166030 |
1.16% |
6176 |
0.53% |
2018-06-30
|
| Gilder Gagnon Howe & CO LLC |
1094716 |
1.09% |
-115706 |
-9.56% |
2018-06-30
|
| State Street Corp |
2250242 |
2.24% |
118425 |
5.56% |
2018-06-30
|
| Goldman, Sachs & Co. |
751215 |
0.75% |
-178479 |
-19.20% |
2018-06-30
|
| Pictet Asset Management SA |
646038 |
0.64% |
292564 |
82.77% |
2018-03-31
|
| 12 West Capital Management LP |
700000 |
0.70% |
-- |
-- |
2018-03-31
|
| Blue Ridge CapHldgsLLC/BluRdgCapOSHldgs |
1338300 |
1.34% |
-193599 |
-12.64% |
2017-12-31
|
| NORGES BANK |
742261 |
0.74% |
77598 |
11.67% |
2017-12-31
|
| BlackRock Advisors LLC |
866689 |
0.87% |
-- |
-- |
2018-02-28
|
| Vanguard Specialized Funds |
6670468 |
6.69% |
-1878889 |
-21.98% |
2017-12-31
|
| HHG PLC |
683020 |
0.74% |
15687 |
2.35% |
2017-09-30
|
| D. E. Shaw & Co LP |
982454 |
1.06% |
248804 |
33.91% |
2017-09-30
|
| Franklin Advisers Inc |
714000 |
0.83% |
122000 |
20.61% |
2016-09-30
|
| Jennison Associates LLC |
781656 |
0.91% |
-193769 |
-19.87% |
2016-09-30
|
| Bridger Management LLC |
983040 |
1.15% |
296031 |
43.09% |
2016-09-30
|
| Slate Path Capital LP |
1225000 |
1.43% |
90000 |
7.93% |
2016-09-30
|
| Eastern Capital LTD |
3802341 |
4.47% |
-1126775 |
-22.86% |
2016-02-25
|
| Wellington Management Group LLP |
8947136 |
1.00% |
839509771 |
0.10% |
1999-11-30
|
| Vanguard Specialized Funds-Vanguard Health Care Fund |
5030100 |
1.00% |
471974283 |
0.10% |
1999-11-30
|
| 共同基金持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| Vanguard US Growth Portfolio |
1018587 |
0.84% |
34033 |
3.46% |
2022-03-31
|
| Vanguard Health Care Fund |
5187603 |
4.29% |
-- |
-- |
2022-03-31
|
| Vanguard Total Stock Market Index Fund |
3485073 |
2.88% |
16754 |
0.48% |
2022-04-30
|
| Dodge & Cox Stock Fund |
3249177 |
2.69% |
-- |
-- |
2022-03-31
|
| Fidelity Growth Company Commingled Pool |
3242908 |
2.68% |
-281014 |
-7.97% |
2022-04-30
|
| Capital Group Growth Fnd of Amer Comp |
3182456 |
2.63% |
3002900 |
1672.40% |
2022-03-31
|
| American Funds Growth Fund of Amer |
3182456 |
2.63% |
3002900 |
1672.40% |
2022-03-31
|
| Vanguard Mid-Cap Index Fund |
2733023 |
2.26% |
3519 |
0.13% |
2022-04-30
|
| Vanguard Extended Market Index Fund |
1595709 |
1.32% |
3315 |
0.21% |
2022-04-30
|
| T. Rowe Price Mid-Cap Growth Fund |
1548000 |
1.28% |
-2000 |
-0.13% |
2022-03-31
|
| T. Rowe Price New Horizons Fund |
1449940 |
1.20% |
124500 |
9.39% |
2022-03-31
|
| Capital Group New Perspective Comp |
1024344 |
0.85% |
1024344 |
-- |
2022-03-31
|
| American Funds New Perspective Fund |
1024344 |
0.85% |
1024344 |
-- |
2022-03-31
|
| BB Biotech AG |
1050000 |
0.87% |
-60000 |
-5.41% |
2022-03-31
|
| Capital Group Growth Composite |
1096390 |
0.91% |
1096390 |
-- |
2022-03-31
|
| American Funds IS |
1096390 |
0.91% |
1096390 |
-- |
2022-03-31
|
| Fidelity |
1270039 |
1.05% |
-- |
-- |
2022-04-30
|
| T. Rowe Price Health Sciences Fund |
1339700 |
1.11% |
125420 |
10.33% |
2022-03-31
|
| iShares Biotechnology ETF |
925229 |
0.77% |
-1442 |
-0.16% |
2022-04-28
|
| Vanguard Growth Index Fund |
958800 |
0.79% |
-3244 |
-0.34% |
2022-03-31
|
| Baillie Gifford US Equity Growth |
1018587 |
0.84% |
34033 |
3.46% |
2022-03-31
|
| Vanguard Mid-Cap Growth Index Fund |
813091 |
0.67% |
19757 |
2.49% |
2022-02-28
|
| Fidelity Advisor |
867015 |
0.72% |
-109371 |
-11.20% |
2021-08-31
|
| iShares Nasdaq Biotechnology ETF |
993097 |
0.84% |
-4470 |
-0.45% |
2021-05-28
|
| Baillie Gifford American Fund |
711776 |
0.61% |
26975 |
3.94% |
2021-01-31
|
| MFS Mid Cap Growth Equity |
703277 |
0.60% |
34913 |
5.22% |
2020-12-31
|
| MFS Mid Cap Growth Fund |
703277 |
0.60% |
-- |
-- |
2021-01-31
|
| MFS Growth Equity |
824528 |
0.71% |
384954 |
87.57% |
2020-09-30
|
| MFS Growth Fund |
681512 |
0.59% |
-143016 |
-17.35% |
2020-11-30
|
| Dodge & Cox Stock Fund |
2653461 |
2.28% |
-81800 |
-2.99% |
2020-09-30
|
| SPDR |
643757 |
0.58% |
-30616 |
-4.54% |
2020-05-31
|
| Hartford MidCap Fund |
799121 |
0.72% |
-- |
-- |
2020-04-30
|
| Federated Kaufmann Large Cap Fd |
630000 |
0.57% |
93800 |
17.49% |
2019-12-31
|
| UBS: Global Equity-UBS |
856794 |
0.77% |
-- |
-- |
2019-06-30
|
| First Trust NYSE Arca Biotech Fund |
803648 |
0.72% |
-18198 |
-2.21% |
2019-09-30
|
| American Century Ultra |
558000 |
0.55% |
172000 |
44.56% |
2018-09-30
|
| T. Rowe Price Institutional Lrg Cp Gr Fd |
840717 |
0.83% |
-90764 |
-9.74% |
2018-03-31
|
| T. Rowe Price Growth Stock Fund |
1815300 |
1.80% |
77180 |
4.44% |
2018-03-31
|
| Dodge & Cox Stock |
2813861 |
2.80% |
-- |
-- |
2018-06-30
|
| Vanguard Total Stock Mkt Idx |
2272798 |
2.26% |
9114 |
0.40% |
2018-07-31
|
| Vanguard Mid Cap Index I |
2147154 |
2.13% |
16889 |
0.79% |
2018-07-31
|
| T. Rowe Price Mid-Cap Growth |
1700000 |
1.69% |
-50000 |
-2.86% |
2018-06-30
|
| iShares Nasdaq Biotechnology |
1140239 |
0.87% |
-2172 |
-0.19% |
2018-09-12
|
| Vanguard Extended Market Idx Inv |
1106380 |
1.10% |
1305 |
0.12% |
2018-07-31
|
| T. Rowe Price Health Sciences |
861255 |
0.86% |
-872477 |
-50.32% |
2018-06-30
|
| Hartford MidCap A |
837832 |
0.83% |
275813 |
49.08% |
2018-07-31
|
| First Trust NYSE Arca Biotech ETF |
701562 |
0.54% |
-- |
-- |
2018-09-13
|
| Vanguard Growth Index Inv |
636255 |
0.63% |
-3651 |
-0.57% |
2018-07-31
|
| Federated Kaufmann Large Cap A |
585000 |
0.58% |
202210 |
52.83% |
2018-06-30
|
| Vanguard Mid-Cap Growth ETF |
548774 |
0.55% |
2468 |
0.45% |
2018-07-31
|
| T. Rowe Price New Horizons |
434088 |
0.43% |
-867300 |
-66.64% |
2018-06-30
|
| Vanguard Health Care Inv |
7782825 |
7.74% |
893408 |
12.97% |
2018-06-30
|
| Morgan Stanley Inst Growth I |
378114 |
0.38% |
107136 |
39.54% |
2018-03-31
|
| T. Rowe Price Instl Large Cap Growth |
840717 |
0.84% |
-90764 |
-9.74% |
2018-03-31
|
| T. Rowe Price Growth Stock |
1815300 |
1.81% |
77180 |
4.44% |
2018-03-31
|
| Dodge & Cox Balanced |
445800 |
0.44% |
-305200 |
-40.64% |
2018-03-31
|
| BlackRock Health Sciences Opps Inv A |
877400 |
0.87% |
24700 |
2.90% |
2018-03-31
|
| Dodge & Cox Global Stock |
671900 |
0.67% |
-160900 |
-19.32% |
2017-12-31
|
| Vanguard Small Cap Index |
1050826 |
1.05% |
2714 |
0.26% |
2018-02-28
|
| Vanguard Small Cap Growth Index Inv |
593240 |
0.60% |
-556903 |
-48.42% |
2017-12-31
|
| Vanguard Explorer Inv |
380080 |
0.44% |
10742 |
2.91% |
2016-09-30
|
| T. Rowe Price Instl Mid-Cap Equity Gr |
291000 |
0.34% |
9500 |
3.37% |
2016-09-30
|
| Prudential Jennison Mid Cap Growth |
496075 |
0.60% |
-- |
-- |
2015-09-30
|
| VA CollegeAmerica Small Cap World |
647603 |
0.80% |
-104000 |
-13.80% |
2015-09-30
|
| Fidelity® Blue Chip Growth Fund |
685563 |
0.80% |
-- |
-- |
2015-09-30
|
| Prudential Jennison Health Sciences |
787111 |
0.90% |
-- |
-- |
2015-09-30
|
| Fidelity® Series Growth Company Fund |
1341551 |
1.60% |
20900 |
1.60% |
2015-09-30
|
| Fidelity® Select Biotechnology Portfolio |
1800278 |
2.10% |
28900 |
1.60% |
2015-09-30
|
| Fidelity® Growth Company Fund |
4899854 |
5.80% |
22199 |
0.50% |
2015-09-30
|
